Artificial intelligence (AI) company Opyl (ASX:OPL) has entered into a non-exclusive partnership with Phenix Health’s Compendium platform to validate clinic trials associated with cannabis products.

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party algorithms and Dandelion's data platform and model validation capabilities to ...

Comparative Analysis of Generative Pre-Trained Transformer Models in Oncogene-Driven Non–Small Cell Lung Cancer: Introducing the Generative Artificial Intelligence Performance Score This ...

Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked AI ...